- Home
- DNTH vs ADTN Comparison
DNTH vs ADTN Comparison
Compare DNTH & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- ADTN
- Stock Information
- Founded
- DNTH 2015
- ADTN 1985
- Country
- DNTH United States
- ADTN United States
- Employees
- DNTH N/A
- ADTN N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- ADTN Telecommunications Equipment
- Sector
- DNTH Health Care
- ADTN Telecommunications
- Exchange
- DNTH Nasdaq
- ADTN Nasdaq
- Market Cap
- DNTH 606.2M
- ADTN 717.9M
- IPO Year
- DNTH N/A
- ADTN 1994
- Fundamental
- Price
- DNTH $21.50
- ADTN $9.23
- Analyst Decision
- DNTH Strong Buy
- ADTN Strong Buy
- Analyst Count
- DNTH 8
- ADTN 4
- Target Price
- DNTH $53.00
- ADTN $12.00
- AVG Volume (30 Days)
- DNTH 387.8K
- ADTN 1.4M
- Earning Date
- DNTH 08-07-2025
- ADTN 08-04-2025
- Dividend Yield
- DNTH N/A
- ADTN N/A
- EPS Growth
- DNTH N/A
- ADTN N/A
- EPS
- DNTH N/A
- ADTN N/A
- Revenue
- DNTH $6,524,000.00
- ADTN $944,291,000.00
- Revenue This Year
- DNTH N/A
- ADTN $13.69
- Revenue Next Year
- DNTH N/A
- ADTN $8.39
- P/E Ratio
- DNTH N/A
- ADTN N/A
- Revenue Growth
- DNTH 102.36
- ADTN N/A
- 52 Week Low
- DNTH $13.37
- ADTN $4.62
- 52 Week High
- DNTH $32.27
- ADTN $12.44
- Technical
- Relative Strength Index (RSI)
- DNTH 61.73
- ADTN 53.65
- Support Level
- DNTH $19.90
- ADTN $9.10
- Resistance Level
- DNTH $22.49
- ADTN $9.65
- Average True Range (ATR)
- DNTH 1.43
- ADTN 0.39
- MACD
- DNTH 0.22
- ADTN -0.06
- Stochastic Oscillator
- DNTH 64.11
- ADTN 34.21
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.